FBXO28 Antibodies

Santa Cruz Biotechnology offers a broad range of FBXO28 monoclonal antibodies for research applications. FBXO28 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FBXO28, a member of the F-box protein family, plays a central role in the ubiquitin-proteasome pathway, which is essential for regulating protein degradation and maintaining cellular homeostasis. FBXO28 participates in various cellular processes, including cell cycle regulation and signal transduction, making it particularly relevant in understanding cancer biology and other diseases. Research focusing on FBXO28 can reveal important insights into protein turnover mechanisms and their implications in pathophysiological conditions. Scientists worldwide utilize FBXO28 monoclonal antibodies to advance their understanding of cellular processes and disease mechanisms. Investigating FBXO28 functions helps unlock new possibilities in therapeutic development and disease treatment strategies. Santa Cruz Biotechnology monoclonal antibodies for FBXO28 enable researchers to make meaningful contributions to scientific knowledge and potential medical breakthroughs.